![]() |
|
|



School of Kinesiology, University of Illinois, Chicago, IL 60608;
* Department of Human Nutrition, University of Illinois, Chicago, IL 60612; and
Section on the Molecular Biology of Selenium, Basic Research Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
3To whom correspondence should be addressed. E-mail: mlc25{at}uic.edu.
Dietary intake of selenium has been implicated in a wide range of health issues, including aging, heart disease and cancer. Selenium deficiency, which can reduce selenoprotein levels, has been associated with several striated muscle pathologies. To investigate the role of selenoproteins in skeletal muscle biology, we used a transgenic mouse (referred to as i6A-) that has reduced levels of selenoproteins due to the introduction and expression of a dominantly acting mutant form of selenocysteine transfer RNA (tRNA[Ser]Sec). As a consequence, each organ contains reduced levels of most selenoproteins, yet these mice are normal with regard to fertility, overall health, behavior and blood chemistries. In the present study, although skeletal muscles from i6A- mice were phenotypically indistinguishable from those of wild-type mice, plantaris muscles were
50% heavier after synergist ablation, a model of exercise overload. Like muscle in wild-type mice, the enhanced growth in the i6A- mice was completely blocked by inhibition of the mammalian target of rapamycin (mTOR) pathway. Muscles of transgenic mice exhibited increased site-specific phosphorylation on both Akt and p70 ribosomal S6 kinase (p70S6k) (P < 0.05) before ablation, perhaps accounting for the enhanced response to synergist ablation. Thus, a single genetic alteration resulted in enhanced skeletal muscle adaptation after exercise, and this is likely through subtle changes in the resting phosphorylation state of growth-related kinases.
KEY WORDS: selenium Akt/PKB transgenic signaling p70 ribosomal S6 kinase
This article has been cited by other articles:
![]() |
T. K. O'Neil, L. R. Duffy, J. W. Frey, and T. A. Hornberger The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions J. Physiol., July 15, 2009; 587(14): 3691 - 3701. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyazaki and K. A. Esser Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals J Appl Physiol, April 1, 2009; 106(4): 1367 - 1373. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Carlson, M. E. Moustafa, A. Sengupta, U. Schweizer, R. Shrimali, M. Rao, N. Zhong, S. Wang, L. Feigenbaum, B. J. Lee, et al. Selective Restoration of the Selenoprotein Population in a Mouse Hepatocyte Selenoproteinless Background with Different Mutant Selenocysteine tRNAs Lacking Um34 J. Biol. Chem., November 9, 2007; 282(45): 32591 - 32602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Riechman, R. D. Andrews, D. A. MacLean, and S. Sheather Statins and Dietary and Serum Cholesterol Are Associated With Increased Lean Mass Following Resistance Training J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2007; 62(10): 1164 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. DiPasquale, M. Cheng, W. Billich, S. A. Huang, N. van Rooijen, T. A. Hornberger, and T. J. Koh Urokinase-type plasminogen activator and macrophages are required for skeletal muscle hypertrophy in mice Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1278 - C1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Hornberger, W. K. Chu, Y. W. Mak, J. W. Hsiung, S. A. Huang, and S. Chien The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle PNAS, March 21, 2006; 103(12): 4741 - 4746. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Nader, T. J. McLoughlin, and K. A. Esser mTOR function in skeletal muscle hypertrophy: increased ribosomal RNA via cell cycle regulators Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1457 - C1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Armstrong and K. A. Esser Wnt/{beta}-catenin signaling activates growth-control genes during overload-induced skeletal muscle hypertrophy Am J Physiol Cell Physiol, October 1, 2005; 289(4): C853 - C859. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. JAMESON and A. M. DIAMOND A regulatory role for Sec tRNA[Ser]Sec in selenoprotein synthesis RNA, July 1, 2004; 10(7): 1142 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lang, K. A. Esser, and E. E. Dupont-Versteegden Altered Activity of Signaling Pathways in Diaphragm and Tibialis Anterior Muscle of Dystrophic Mice Experimental Biology and Medicine, June 1, 2004; 229(6): 503 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schweizer, L. Schomburg, and N. E. Savaskan The Neurobiology of Selenium: Lessons from Transgenic Mice J. Nutr., April 1, 2004; 134(4): 707 - 710. [Abstract] [Full Text] [PDF] |
||||